• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病因子的清除。

Clearance of von Willebrand factor.

机构信息

Unit 770, INSERM, Le Kremlin-Bicêtre, France; UMR_S 770, Univ Paris-Sud, Le Kremlin-Bicêtre, France.

出版信息

J Thromb Haemost. 2013 Jun;11 Suppl 1:202-11. doi: 10.1111/jth.12226.

DOI:10.1111/jth.12226
PMID:23809124
Abstract

Quantitative deficiencies in von Willebrand factor (VWF) are associated with abnormal hemostasis that can manifest in bleeding or thrombotic complications. Consequently, many studies have endeavored to elucidate the mechanisms underlying the regulation of VWF plasma levels. This review focuses on the role of VWF clearance pathways. A summary of recent developments are provided, including results from genetic studies, the relationship between glycosylation and VWF clearance, the contribution of increased VWF clearance to the pathogenesis of von Willebrand disease and the identification of VWF clearance receptors. These different studies converge in their conclusion that VWF clearance is a complex phenomenon that involves multiple mechanisms. Deciphering how such different mechanisms coordinate their role in this process is but one of the remaining challenges. Nevertheless, a better insight into the complex clearance pathways of VWF may help us to better understand the clinical implications of aberrant clearance in the pathogenesis of von Willebrand disease and perhaps other disorders as well as aid in developing alternative therapeutic approaches.

摘要

血管性血友病因子(VWF)的定量缺乏与异常止血有关,可表现为出血或血栓并发症。因此,许多研究都致力于阐明 VWF 血浆水平调节的机制。本综述重点介绍 VWF 清除途径的作用。提供了最近研究结果的总结,包括遗传研究的结果、糖基化与 VWF 清除的关系、VWF 清除增加对血管性血友病发病机制的贡献以及 VWF 清除受体的鉴定。这些不同的研究都得出结论,VWF 的清除是一种复杂的现象,涉及多种机制。阐明这些不同的机制如何协调它们在这个过程中的作用是仍然存在的挑战之一。然而,更好地了解 VWF 的复杂清除途径可能有助于我们更好地理解血管性血友病发病机制中异常清除的临床意义,也许还有其他疾病,并有助于开发替代治疗方法。

相似文献

1
Clearance of von Willebrand factor.血管性血友病因子的清除。
J Thromb Haemost. 2013 Jun;11 Suppl 1:202-11. doi: 10.1111/jth.12226.
2
Genetic regulation of plasma von Willebrand factor levels in health and disease.遗传调控健康和疾病状态下的血浆血管性血友病因子水平。
J Thromb Haemost. 2018 Dec;16(12):2375-2390. doi: 10.1111/jth.14304. Epub 2018 Oct 30.
3
N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.N-连接聚糖缩短导致血浆源性血管性血友病因子清除增强。
J Thromb Haemost. 2016 Dec;14(12):2446-2457. doi: 10.1111/jth.13537. Epub 2016 Dec 9.
4
Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.1型血管性血友病队列中去氨加压素释放后血管性血友病因子的存活:糖基化、蛋白水解和基因突变的影响
Thromb Haemost. 2008 May;99(5):916-24. doi: 10.1160/TH07-09-0565.
5
von Willebrand factor sialylation-A critical regulator of biological function.血管性血友病因子的唾液酸化——生物学功能的关键调节物。
J Thromb Haemost. 2019 Jul;17(7):1018-1029. doi: 10.1111/jth.14471. Epub 2019 May 30.
6
von Willebrand factor clearance - biological mechanisms and clinical significance.血管性血友病因子清除 - 生物学机制与临床意义。
Br J Haematol. 2018 Oct;183(2):185-195. doi: 10.1111/bjh.15565.
7
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.2N 型血管性血友病小鼠中异常 von Willebrand 因子分泌、因子 VIII 稳定和血栓动力学。
J Thromb Haemost. 2017 Aug;15(8):1607-1619. doi: 10.1111/jth.13749. Epub 2017 Jul 17.
8
Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease.综述文章:手术室中意外出血:获得性血管性血友病的作用。
Anesth Analg. 2012 Jan;114(1):73-81. doi: 10.1213/ANE.0b013e318236b16a. Epub 2011 Oct 24.
9
Clearance of von Willebrand factor.血管性血友病因子的清除
Thromb Haemost. 2008 Feb;99(2):271-8. doi: 10.1160/TH07-10-0629.
10
Increased galactose expression and enhanced clearance in patients with low von Willebrand factor.低血管性血友病因子患者的半乳糖表达增加和清除增强。
Blood. 2019 Apr 4;133(14):1585-1596. doi: 10.1182/blood-2018-09-874636. Epub 2019 Feb 15.

引用本文的文献

1
Heparan sulfate proteoglycans remodel SARS-CoV-2 spike conformation to allow integrin interaction and infection of endothelial cells.硫酸乙酰肝素蛋白聚糖重塑严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白构象,以实现整合素相互作用并感染内皮细胞。
Front Cell Infect Microbiol. 2025 Apr 3;15:1552116. doi: 10.3389/fcimb.2025.1552116. eCollection 2025.
2
Investigation of serum neurofilament light chain as a biomarker in Fabry disease.研究血清神经丝轻链作为法布里病的生物标志物。
Sci Rep. 2024 Oct 3;14(1):23033. doi: 10.1038/s41598-024-73537-y.
3
R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.
R1205H(Vicenza)导致血管性血友病因子 D'D3 结构域发生构象变化,并增强血管性血友病因子与清除受体 LRP1 和 SR-AI 的结合。
J Thromb Haemost. 2024 Oct;22(10):2752-2760. doi: 10.1016/j.jtha.2024.06.023. Epub 2024 Jul 10.
4
The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1.适体 BT200 阻断了 VWF-A1 结构域中 K1405-K1408 与巨噬细胞 LRP1 的相互作用。
Blood. 2024 Sep 26;144(13):1445-1456. doi: 10.1182/blood.2024024055.
5
Association of blood group O with a recurrent risk for acute lower gastrointestinal bleeding from a multicenter cohort study.血型 O 与多中心队列研究中急性下消化道出血再发风险的相关性。
Sci Rep. 2024 Jun 17;14(1):13983. doi: 10.1038/s41598-024-64476-9.
6
Application of genetic testing for the diagnosis of von Willebrand disease.遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
7
Novel functions for von Willebrand factor.血管性血友病因子的新功能。
Blood. 2024 Sep 19;144(12):1247-1256. doi: 10.1182/blood.2023021915.
8
An Investigation of ABO Blood Type and the Platelet Delta Granule Storage Pool.ABO 血型与血小板δ颗粒储存池研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211068818. doi: 10.1177/10760296211068818.
9
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial.BT200,一种 von Willebrand 因子 A1 结构域结合适体,可提升 von Willebrand 因子和因子 VIII 的血浆水平:一项首次人体试验。
Haematologica. 2022 Sep 1;107(9):2121-2132. doi: 10.3324/haematol.2021.279948.
10
Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders.新型冠状病毒肺炎中的高凝状态:凝血障碍潜在机制综述
SAGE Open Med. 2021 Mar 21;9:20503121211002996. doi: 10.1177/20503121211002996. eCollection 2021.